Description
SLU-PP-332 is a synthetic small-molecule metabolic modulator studied for its effects on mitochondrial uncoupling, energy expenditure, and fat oxidation. Unlike peptides, this compound is designed to target cellular energy pathways directly at the mitochondrial level, with interest in obesity, weight management, and metabolic health research.
Benefits
- Metabolic activation — studied for increasing energy expenditure via mitochondrial uncoupling.
- Fat oxidation — explored for shifting metabolism toward greater fat utilization.
- Weight management — preclinical models show reductions in fat mass and body weight.
- Mitochondrial health — interest in improving efficiency and reducing cellular stress.
- Metabolic flexibility — supports adaptation to different energy demands in research studies.
What researchers look at
- Mechanism: mitochondrial uncoupling and proton gradient modulation.
- Effects on fatty acid oxidation and thermogenesis in animal models.
- Research into obesity and metabolic syndrome treatment strategies.
- Comparison with earlier uncoupling agents (e.g., DNP) for safety and efficacy.
Quick Specs
- Form: Capsules
- Dose per capsule: 250 mcg
- Bottle count: 30 capsules
- Purity: ≥99% (HPLC)
- Storage: Store in a cool, dry place
Identity Basics
- Type: Synthetic small molecule (non-peptide)
- Formula / M.W.: Not publicly disclosed in full literature
- CAS: Not assigned
Selected Research
- SLU-PP-332 mitochondrial uncoupler overview:
https://pubmed.ncbi.nlm.nih.gov/34272340/
- Mitochondrial uncoupling and fat oxidation:
https://pubmed.ncbi.nlm.nih.gov/32127458/
- Energy expenditure and weight loss in models:
https://pubmed.ncbi.nlm.nih.gov/34312454/
⚠️ Disclaimer
-
This product is intended for laboratory research use only.
-
Not for human or veterinary use.
-
Not approved for diagnostic, therapeutic, or medical applications.
-
Handle using appropriate laboratory safety procedures and personal protective equipment.
